Live Breaking News & Updates on வாழ்க்கை அறிவியல் மாநாடு

Stay updated with breaking news from வாழ்க்கை அறிவியல் மாநாடு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

iTeos Therapeutics Inc.: iTeos Reports Second Quarter 2021 Financial Results and Provides Business Update

Announced co-development and co-commercialization collaboration with GSK for anti-TIGIT monoclonal antibody EOS-448 (GSK'859); $625MM upfront payment in addition to $1.45B in potential milestones, 40/60 ....

United Kingdom , United States , Waals Gewest , Michel Detheux , Bryan Baker , Company Collaboration , Teos Therapeutics Inc , American Society Of Clinical Oncology , Securities Life Sciences Conference , Exchange Commission , Trademark Office , Development Rd Expenses , American Association For Cancer Research , Teos Therapeutics , American Association , Cancer Research , Immunomodulatory Drug , Clinical Oncology , Investigational New Drug Enabling , Life Sciences Conference , Fargo Healthcare Conference , Stanley Global Healthcare Conference , Global Investment Conference , Fitzgerald Global Healthcare Conference , License Agreement , Call Details ,

Hyloris Reports 2021 Half-Year Results: Multiple Potential Value Inflection Points Ahead

Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Hyloris Reports 2021 Half-Year Results: Multiple Potential Value Inflection Points Ahead
Hyloris Pharmaceuticals SAAugust 4, 2021 GMT
On target to grow the broad product pipeline with at least 3 additional programmes before end 2021
Significant expansion of commercial footprint of non-opioid pain treatment Maxigesic® IV
Expected to start 2 clinical studies and to report the results from 2 clinical studies before year-end
€53.47 million in cash and cash equivalents to execute ambitious growth strategy
Conference call and webcast today at 3pm CEST/9am EST (details below)
Liège, Belgium – 4 August 2021 – Hyloris Pharmaceuticals SA (Euronext Brussels: HYL), a specialty biopharma company committed to addressing unmet medical needs through reinventing existing medications, today reports its condensed consolidated financial results for the six-month p ....

United States , United Kingdom , Marieke Vermeersch , Stijn Van Rompay , Miconazole Domiphen , Olivier Declercq , Chris Buyse , Alter Pharma Group For Maxigesic , Alter Pharma Group , International Standard On Review Engagements , Hyloris Pharmaceuticals , Company Group Structure , Hyloris Pharmaceuticals Sa Euronext Brussels , Corporate Communications , Pharma Bavaria International , Hikma Pharmaceuticals , Euronext Brussels , Van Rompay , Chief Executive Officer , South America , Latin America , Purna Female Healthcare , Miconazole Domiphen Bromide , Tranexamic Acid , Fusidic Acid , Alter Pharma ,

Investegate |INVENTIVA Announcements | INVENTIVA: Inventiva Reports First-Half of 2021 Financial Information

Investegate |INVENTIVA Announcements | INVENTIVA: Inventiva Reports First-Half of 2021 Financial Information
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

United States , France General , City Of , United Kingdom , Îe De France , Pascaline Clerc , Yannick Tetzlaff , Aude Lepreux , Patricial Bank , Company Phase , Brunswick Group , Exchange Commission On , Portzamparc Health Biotech Seminar , Bourse Forum , Global External Affairs , Research Tax Credit , Inventiva Reports First Half , Euronext Paris , Tax Credit , Non Alcoholic Fatty Liver Disease , Annual Biopharma Conference , Life Science Conference , Annual Global Investment Conference , Tech Innovation Days , Health Biotech Seminar , Disease Day ,

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) - The Week Ahead In Biotech: Takeda, Blueprint Medicines, Orphazyme, Eton On The Radar Ahead Of FDA Decisions, IPOs

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) - The Week Ahead In Biotech: Takeda, Blueprint Medicines, Orphazyme, Eton On The Radar Ahead Of FDA Decisions, IPOs
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

United States , South San Francisco , Los Altos , Alliance Global Partners Healthcare Symposium Virtual , European Hematology Association Congress , Takeda Pharmaceutical Company Limited , Biogen Inc , Health Care Conferences , Vertex Pharmaceuticals Incorporated , Pfizer Inc , Cytrx Corporation , Lyell Immunopharma Inc , Blueprint Medicines Corporation , Galecto Inc , Securities Life Sciences Conference , Eton Pharmaceuticals Inc , Atai Life Sciences , Alexion Pharmaceuticals Inc , Bofa Securities , Biopharma Virtual Conference , European Healthcare Day , Life Sciences Conference , European Healthcare Conference , Global Partners Healthcare Symposium Virtual , Beyond Virtual Conference , Attention Biotech Investors ,

Investegate |Minerva Neurosciences, Inc Announcements | Minerva Neurosciences, Inc: Minerva Neurosciences to Present at JMP Securities Life Sciences Conference

Investegate announcements from Minerva Neurosciences, Inc, Minerva Neurosciences to Present at JMP Securities Life Sciences Conference ....

United Kingdom , Minerva Neurosciences , Williamb Boni , Securities Life Sciences Conference , Minerva Neurosciences Inc , Securities Life Sciences Conference On , Life Sciences , Life Sciences Conference , Investegate Announcements , Investegate Company Announcements , Minerva Neurosciences , Lobenewswire And Globenewswire , ஒன்றுபட்டது கிஂக்டம் , மினெர்வா நரம்பியல் , பத்திரங்கள் வாழ்க்கை அறிவியல் மாநாடு , மினெர்வா நரம்பியல் இன்க் , வாழ்க்கை அறிவியல் , வாழ்க்கை அறிவியல் மாநாடு ,